Develops and investigates therapy options for patients.
Chiesi is a research-oriented international biopharmaceutical group.
To advance the wellbeing of society.
Empowering patients with allergies, airways, and atopic disease around the world.
Gossamer Bio is a clinical-stage biopharmaceutical company.
We believe challenging something is the best way to change it.
Focused on the development and commercialization of products in pulmonary hypertension.
Save and improve lives around the world.
Innovation, modernste Technik und progressive Therapiekonzepte.
Committed to transforming the lives of patients with pulmonary diseases.
Leading the fight for breath.